A p21 carboxyl-terminal peptide exhibited cyclin dependent kinase inhibitory activity and cytotoxicity when introduced into human cells - Mutoh,M.; Lung,F.; Long,Y.; Roller,P.; Sikorski,R.; O'Connor,P. (Cancer Res, 1999)